Archive for August 11th, 2026

If you had a neuroendocrine tumor, would you be willing to try a radioactive drug as a small part of your treatment?

https://www.ovid.com/jnls/cnmo/fulltext/10.1097/nm9.0000000000000092~implementing-212-pb-targeted-alpha-therapy-a-safety-first If you had a ๐ง๐ž๐ฎ๐ซ๐จ๐ž๐ง๐๐จ๐œ๐ซ๐ข๐ง๐ž ๐ญ๐ฎ๐ฆ๐จ๐ซ ๐ข๐ง ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐ญ๐จ๐ฆ๐š๐œ๐ก, ๐ฌ๐ฆ๐š๐ฅ๐ฅ ๐ข๐ง๐ญ๐ž๐ฌ๐ญ๐ข๐ง๐ž, ๐š๐ฉ๐ฉ๐ž๐ง๐๐ข๐ฑ, ๐œ๐จ๐ฅ๐จ๐ง, ๐ฉ๐š๐ง๐œ๐ซ๐ž๐š๐ฌ, ๐ฅ๐ฎ๐ง๐ ๐ฌ, ๐š๐๐ซ๐ž๐ง๐š๐ฅ ๐ ๐ฅ๐š๐ง๐๐ฌ, ๐ญ๐ก๐ฒ๐ซ๐จ๐ข๐, ๐ฉ๐ข๐ญ๐ฎ๐ข๐ญ๐š๐ซ๐ฒ, ๐ซ๐ž๐œ๐ญ๐ฎ๐ฆ, ๐›๐ซ๐ž๐š๐ฌ๐ญ, ๐จ๐ซ ๐ฉ๐ซ๐จ๐ฌ๐ญ๐š๐ญ๐ž, ๐ฐ๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐ฐ๐š๐ง๐ญ ๐ญ๐จ ๐ญ๐ซ๐ฒ ๐š ๐ซ๐š๐๐ข๐จ๐š๐œ๐ญ๐ข๐ฏ๐ž ๐๐ซ๐ฎ๐ ย as (a small) part of the treatment? The emerging clinical dataset highlights excellent short-term tolerability for 212Pb-TAT, with adverse events primarily consisting of low-grade […]